NDT Advance Access originally published online on March 17, 2009
Nephrology Dialysis Transplantation 2009 24(7):2286-2287; doi:10.1093/ndt/gfp108
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Treatment of type 2 diabetes in chronic kidney disease: meekly follow the herd or call to arms?
| The first 10% of the full text of this article appears below. |
Sir,
In the February issue of Nephrology Dialysis and Transplantation, Haneda and Morikawa [1] reported their view on the treatment of type 2 diabetes in patients with chronic kidney disease (CKD) stages 3–5. Whereas the authors should be commended with their bravery to take up this important topic, they failed to recognize the far reaching scientific, medical, socio-economic and ethical problems related to this field of medicine, by meekly following the conclusions of what others have written, without searching for the underlying evidence. If they would have done that, they would have recognized without any doubt that there is a surprising lack of evidence
Renal Division, University Hospital Ghent, Belgium E-mail: wim.vanbiesen@ugent.be